Evidence map›Paper›PMID 38470883›Full record

ArticleDatabase : the journal of biological databases and curation2024

AagingBase: a comprehensive database of anti-aging peptides.

Kunjulakshmi R, Ambuj Kumar, Keerthana Vinod Kumar, Avik Sengupta, Kavita Kundal, Simran Sharma, Ankita Pawar, Pithani Sai Krishna, Mohammad Alfatah, Sandipan Ray and 2 more

Abstract read
In one paragraph

Article in Database : the journal of biological databases and curation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kunjulakshmi RDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.
Ambuj KumarDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.
Keerthana Vinod KumarDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.
Avik SenguptaDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.
Kavita KundalDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.
Simran SharmaDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.
Ankita PawarSchool of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O., Kollam, Kerala 690525, India.
Pithani Sai KrishnaSchool of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O., Kollam, Kerala 690525, India.
Mohammad AlfatahBioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, Matrix #07-01, Singapore 138671, Republic of Singapore.
Sandipan RayDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.ORCID 0000-0002-9960-5768
Bhavana TiwariDepartment of Biological Sciences, Indian Institute of Science Education and Research, Berhampur, Odisha 760010, India.
Rahul KumarDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.ORCID 0000-0002-6927-5390

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The process of aging is an intrinsic and inevitable aspect of life that impacts every living organism. As biotechnological advancements continue to shape our understanding of medicine, peptide therapeutics have emerged as a promising strategy for anti-aging interventions. This is primarily due to their favorable attributes, such as low immunogenicity and cost-effective production. Peptide-based treatments have garnered widespread acceptance and interest in aging research, particularly in the context of age-related therapies. To effectively develop anti-aging treatments, a comprehensive understanding of the physicochemical characteristics of anti-aging peptides is essential. Factors such as amino acid composition, instability index, hydrophobic areas and other relevant properties significantly determine their efficacy as potential therapeutic agents. Consequently, the creation of 'AagingBase', a comprehensive database for anti-aging peptides, aims to facilitate research on aging by leveraging the potential of peptide therapies. AagingBase houses experimentally validated 282 anti-aging peptides collected from 54 research articles and 236 patents. Employing state-of-the-art computational techniques, the acquired sequences have undergone rigorous physicochemical calculations. Furthermore, AagingBase presents users with various informative analyses highlighting atomic compositions, secondary structure fractions, tertiary structure, amino acid compositions and frequencies. The database also offers advanced search and filtering options and similarity search, thereby aiding researchers in understanding their biological functions. Hence, the database enables efficient identification and prioritization of potential peptide candidates in geriatric medicine and holds immense potential for advancing geriatric medicine research and innovations. AagingBase can be accessed without any restriction. Database URL: https://project.iith.ac.in/cgntlab/aagingbase/.

Indexed as

Data ManagementPeptidesAmino AcidsDatabases, FactualAmino AcidsPeptides

Identifiers

PMID38470883
PMCPMC10930205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.